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Background: Cancers are commonly characterised by hypoxia and also by global reductions in the levels of
mature microRNAs. We have examined the hypothesis that hypoxia might mediate this reduction through
repressive effects on microRNA biogenesis proteins.
Methods: Breast cancer cell lines were exposed to hypoxia and manipulations of hypoxia inducible factor (HIF) and
HIF hydroxylase activity. The effects of hypoxia on the mRNA and protein levels of enzymes involved in microRNA
biogenesis (Dicer, Drosha, TARPB2, DCGR8, XPO5) was determined by RT PCR and immunoblotting. The effect of
hypoxia on microRNAs was determined with microarray studies, RT PCR and reporter assays.
Results: In breast cancer lines there was significant reduction of Dicer mRNA and protein levels in cells exposed to
hypoxia. This effect was independent of HIF but dependent on the HIF hydroxylase PHD2 and was partly mediated
by feedback effects via microRNAs. Furthermore, several other proteins with critical roles in microRNA biogenesis
(Drosha, TARBP2 and DCGR8) also showed significant and co-ordinated repression under hypoxic conditions.
Despite these substantial alterations no, or modest, changes were observed in mature microRNA production.
Conclusion: These observations provide further and important interfaces between oxygen availability and gene
expression and a potential mechanistic explanation for the reduced levels of microRNAs observed in some cancers.
They provide further support for the existence of feedback mechanisms in the regulation of the microRNA
biogenesis pathway and the relative stability of microRNAs.
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Hypoxia is a key feature of many cancers and the presence
of hypoxia is associated with more aggressive and meta-
static tumours [1-3]. The exposure of cells to hypoxia
leads to the co-ordinated regulation of many genes. The
protein products of these genes have a wide variety of crit-
ical roles in processes such as metabolism, angiogenesis,
growth and apoptosis. Studies of the mechanisms under-
lying the regulation of such genes have implicated a cen-
tral role for the transcription factor hypoxia inducible
factor (HIF). Many cancers are characterised by enhanced
HIF levels and increased expression of hypoxically regu-
lated genes which correlate both with tumour aggression
and patient outcome [4]. The extent to which hypoxia
contributes to enhanced tumour aggression via metabolic* Correspondence: jonathan.gleadle@health.sa.gov.au
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modifications remains incompletely understood. In addition
to the transcriptional regulation of mRNA, hypoxia can also
influence mRNA stability, translation, protein stability
and microRNA generation. Hypoxia also leads to the
co-ordinated repression of many genes but the mechan-
ism for such effects is less well defined.
MicroRNAs (miRNAs) are 17–22 nucleotide, non-
coding, single stranded RNA molecules that are import-
ant regulators of gene expression. MicroRNAs are tran-
scribed as primary transcripts (pri-miRNAs) by RNA
Polymerase II [5] or III [6] enzymes. In the nucleus, pri-
miRNAs are cleaved by the nuclear RNase III enzyme
Drosha and cofactor protein DGCR8 (DiGeorge syn-
drome critical region gene 8) to generate a precursor
miRNA (pre-miRNA) (about 70 nucleotides long) [7].
The pre-miRNAs are exported to the cytoplasm by the
karyopherin, exportin-5 [8]. In the cytoplasm, pre-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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enzyme [9,10], coupled with TARBP2 (Tar RNA binding
protein 2) [11,12] to generate a 22 nucleotide double
stranded miRNA duplex. One strand of the RNA duplex
functions as the mature miRNA and often the passenger
strand will be degraded by endonucleases [13]. In some
instances the passenger strand (previously referred to as
the star form) is not degraded and may also function as a
mature miRNA [14,15]. The two strands of the duplex are
separated by an RNA helicase (DDX5) and the miRNA
then binds to mRNA within the RNA induced silencing
complex, containing an Argonaute protein, leading to ei-
ther translational inhibition or destruction of the target
mRNA [16].
Functional studies show that miRNAs are involved in
regulating many cellular processes including developmental
timing, cell differentiation, cell proliferation and cell death
[17,18]. The expression levels of many miRNAs are deregu-
lated in human disease conditions including cancer [19-23].
In addition to deregulation of specific miRNAs in cancer, it
has emerged that most tumour cell lines and cancers are
characterised by global reductions in miRNA expression
[24,25] when compared to adjacent normal tissue. Whilst it
has been postulated that this reduction in miRNA expres-
sion is a feature of a loss of differentiation, the mechanisms
underlying this global reduction in miRNA expression in
many cancers are unknown, though some evidence exists
for post-transcriptional control [25,26].
It has recently been suggested that genetic polymor-
phisms of the genes encoding miRNA generating proteins
may affect renal cell carcinoma susceptibility [27]. Indeed
for other cancers such as ovarian and lung tumours, low
levels of Drosha [28] and Dicer [28,29] have been shown
to correlate with poor patient outcome. Dicer1 is a hap-
loinsufficient tumour suppressor in human cancer and
loss of one Dicer1 allele is sufficient for the formation of
tumours in breast, kidney, stomach, intestine, liver, lungs
and pancreas [30]. Furthermore, miRNAs are central to
the process of angiogenesis (for review see [31]). Exposure
to hypoxia alters specific miRNA expression [32-35] with
miRNAs such as miR-210 showing marked hypoxic induc-
tion and capacity to act as markers of patient prognosis in
breast cancer [35].
The links between tumour hypoxia, miRNA expression
and cancer aggression raise the possibility of a general ef-
fect of hypoxia on miRNA biogenesis and function. Dur-
ing our microarray study examining mRNA expression in
the breast cancer cell line MCF7, we saw a modest but
consistent decrease in Dicer mRNA levels after exposure
to hypoxia [36]. In this work we investigate the possibility
that hypoxic regulation of expression of miRNA biogen-
esis proteins might contribute to the reduction in miRNA
expression in many tumours and to the role of hypoxia in
cancer progression.Methods
Cell culture
Breast cancer cell lines (MCF7 and SKBR3) and colorectal
cancer cell line (HT29) were obtained from the American
Type Culture Collection (Manassas, VA, USA). The col-
lection of primary human umbilical vein endothelial cells
(HUVEC) for use in this study was given ethical clearance
from the Royal Adelaide Hospital (RAH), Adelaide, South
Australia. Consent was obtained from all subjects in ac-
cordance with the ‘Declaration of Helsinki’ and conforms
to the guidelines established by the National Health and
Medical Research Council of Australia.
Breast cancer cell lines (MCF7 and SKBR3) and colorec-
tal cancer cell line (HT29) were maintained in RPMI 1640
(Invitrogen) medium supplemented with 10% foetal bo-
vine serum (FBS) (Bovigen). Primary cell line human um-
bilical vein endothelial cells (HUVECs) were maintained
in polystyrene flasks coated with gelatine in Media 200
PRF (Invitrogen) supplemented with 20% FBS (Bovigen).
Cells were maintained at 37°C with 5% CO2. All experi-
ments were conducted in triplicate with independent cell
cultures. Independently treated cultures were treated as
technical replicates.
Cell treatments
Cells were treated with 1 mM dimethyloxalylglycine
(DMOG) (Enzo Life Sciences) and incubated at 37°C in a
normoxic incubator for 48 h. Similarly cells were treated
with 0.1 mM Desferrioxamine (Sigma-Aldrich) and incu-
bated at 37°C in a normoxic incubator for 48 h.Exposure of cells to hypoxia
A hypoxic incubator (Coy Laboratory Hypoxic workstation
glove box) was used to expose cells to continuous con-
trolled hypoxic conditions. This humidified, temperature
controlled (37°C) chamber was supplemented with 5%
CO2, and N2 (as required to maintain controlled O2 levels).
Cells were exposed to 0.1% O2 levels or 1% O2 for varying
durations. Normoxic controls were incubated in parallel in
a humidified incubator supplemented with 5% CO2 at 37°C.RNA interference
Cells were seeded at 5 × 104 cells per well in 24-well
plates (1.9 cm2) and grown for 24 h. Cells were trans-
fected with 20 nM siRNA duplexes (Shanghai Gene-
Pharma Co., Ltd, China), using Lipofectamine 2000
reagent (Invitrogen) following the manufacturer’s proto-
col. A second transfection was carried out after 24 h fol-
lowing the same protocol. Cells were harvested 24 h
after the second transfection and used for RNA and
protein extraction. List of siRNAs used are provided
(see Additional file 1: Table S1).
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Cells were seeded at 5 × 104 cells per well in 24-well plates
and grown for 24 h. Cells were transfected with 20 nM
miRNA mimic, inhibitors or antagomirs (Shanghai Gene-
Pharma Co., Ltd, China), using Lipofectamine 2000 reagent
(Invitrogen) following the manufacturer’s protocol. Cells
were harvested 24 h after the transfection and used for
RNA and protein extraction.
Plasmid DNA transfection
A plasmid construct containing the 3’UTR of the ZEB1
gene, downstream of Renilla luciferase (RL), in a CMV pro-
moted RL reporter (pCI-neo-hRL) was used [37]. ZEB1 is
an E-cadherin transcriptional repressor involved in epithe-
lial to mesenchymal transition of tissues and is regulated by
the mir-200 family. To over-express miR-200b levels we
used a plasmid expressing a precursor miR-200b from a
CMV promoter (pCMV-miR-200b) and an empty vector
was used as the control plasmid (Origene).
The RL reporter plasmids (3.6 fmol), pGL3-control
(Promega) (500 ng for normalisation) and pCMV-miR-
200b/pCMV-miR plasmid (250 ng) were co-transfected
with Lipofectamine 2000 (Invitrogen) into SKBR3 cells
seeded in 24-well plates (1 × 105 cells per well). The total
amount of DNA in each transfection was made up to 1 μg
with unrelated plasmid DNA (pcDNA 3.1+). Two hours
after transfection, half the plates were incubated at 0.1%
O2 for 24 h and control plates were incubated at normoxic
conditions. After the 48 h incubation cells were assayed
using the dual-luciferase reporter assay system (Promega).
All experiments were performed in triplicate. Lumines-
cence was measured using a plate reader luminometer
(Beckman Coulter DTX 880 Multimode detector).
RNA extraction and real time PCR
Total RNA was extracted using TRIzol reagent (Invitro-
gen) following the manufacturers protocol. RNA quantity
and quality were determined using a Nanodrop-8000
spectrophotometer (Nanodrop Technology) and Agilent
2100 Bioanalyzer. For miRNA analysis complementary
DNA (cDNA) was synthesised from 5 ng of total RNA
using Taqman miRNA specific primers and Taqman
miRNA reverse transcription kit (Applied Biosystems).
Small nucleolar RNA, RNU6B, was used as a control gene.
For parallel detection of mature and pre-miRNAs, cDNA
was synthesised from 1 μg of RNA using the miScript II
RT kit. Mature miRNAs were analysed using miScript pri-
mer assays and precursor miRNAs were analysed using
miScript precursor assays. For mRNA analysis cDNA was
randomly primed from 1 μg of total RNA following DNase
1 treatment (New England Labs) using M-MLV reverse
transcriptase RNase H minus, point mutant (Promega)
and Random primer 6 (New England Labs). Real time
PCR was subsequently performed in triplicate with 1:5dilution of cDNA using Taqman gene expression assays.
Beta-2-microglobulin and ribosomal RNA 18S were used
to normalise mRNA expression. Relative quantification by
RT-PCR was performed using the Corbett Roto-gene 6000
and data analysed using Corbett Rotogene software (Ver-
sion 5.0.61) (Corbett Research).
Microarray analysis
Total RNA from MCF7 cells, exposed to hypoxia or nor-
moxia, was extracted using the TRIzol protocol as above.
RNA integrity was assessed using the Agilent 2100 Bioa-
nalyzer. Affymetrix miRNA 3.1 Array Strip was used for
RNA analysis. This array consisted probe sets unique to
human mature and pre-miRNA hairpins. A detailed proto-
col can be found in the miRNA 3.1 Array Strips technical
manual (Affymetrix). In summary, 100–300 ng of total
RNA was used to synthesise double stranded cDNA using
random hexamers. The cDNA was then amplified to pro-
duce antisense cRNA, which was then reverse transcribed
in a second cycle of cDNA synthesis. The second cycle in-
corporates dUTP into the cDNA sequence, which allows
it to be fragmented using uracil DNA glycosylase and
apurinic/apyrimidic endonuclease I. Following biotinyl-
ation, these fragments were hybridised overnight to a Affy-
metrix miRNA 3.1 array. The arrays were then washed,
stained using a fluorescently-labelled antibody, and
scanned using a high-resolution scanner. Intensity data
were analysed using Partek® software (Partek Inc.). Data
were normalised by quantile normalisation and log2 trans-
formed. Differential expression was determined by
ANOVA and corrected for false discovery. The microarray
data have been deposited in NCBI’s Gene Expression
Omnibus [38] and are accessible through GEO Series ac-
cession number GSE49999.
Immunoblotting
Cell lysates were prepared by adding lysis buffer (6.7 M
urea, 10 mM Tris–HCl (pH 6.8), 10% glycerol, 1% SDS,
supplemented with 1 mM DTT and Complete mini prote-
ase inhibitor cocktail tablets (Roche Applied Science, UK)
just before use, to cells washed with 1× phosphate
buffered saline solution. Total protein extracts were
resolved on an 8% SDS polyacrylamide gel or a Mini-
PROTEAN TGX precast Any kD gradient gel (Bio-Rad
Laboratories, Inc.) electrophoresis and transferred to a
polyvinylidene difluoride membrane (Millipore). The
use of Mini-PROTEAN TGX precast gels allowed for
imaging the total protein loaded in each lane on the gel
and on the PVDF membrane after the transfer. The
membrane was blocked with 5% skim milk in 1xTBS-T
for 1 h at room temperature and incubated with pri-
mary antibody overnight at 4°C, then washed with
1xTBS-T and incubated with the appropriate horserad-
ish peroxidise conjugated secondary antibodies for 1 h
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(ECL) (GE health care) system was used to detect bands,
which were imaged with a Chemi-Doc MP system (Bio-
Rad). Densitometry was performed using the ImageLab
software version 4.0 (BioRad). Protein levels were normal-
ised to β-tubulin, α-actinin or to total protein levels on the
PVDF membrane after the transfer. Quantified results rep-
resent n = 3 samples. Statistical significance determined
using Student’s t-test (P < 0.05).
Results
The effect of hypoxia on Dicer protein levels in breast
cancer cell lines
Hypoxic regulation of Dicer gene expression was initially
measured at the protein level. Dicer protein levels in two
different breast cancer cell lines (MCF7 and SKBR3 cells)
exposed to hypoxia (0.1% O2) were examined by immuno-
blotting. After 16 h and 24 h of hypoxia (0.1% O2) no, or
very modest, reductions in Dicer protein abundance were
seen (see for example Figure 1A and Figure 1B). To ac-
commodate the possibility that hypoxic alterations inFigure 1 Dicer protein expression in hypoxia vs. normoxia. Dicer prote
exposure to different O2 concentrations for different durations. A, Dicer pro
B, 24 h. C, Dicer protein expression in MCF7 cells after exposure to 0.1% O2
0.1% O2 for 48 h. E, Dicer protein expression in SKBR3 cells after exposure t
to 1% O2 for 24 h. G, Dicer protein expression in HUVECs after exposure to
examined by immunoblotting. Results show three technical replicates per tDicer levels were not seen at earlier time points because
of significant stability of the Dicer protein, we examined
the effects of longer durations of hypoxia. A striking
reduction in Dicer protein levels was seen in both MCF7
(5 -fold) (Figure 1C) and SKBR3 cells (40-fold) (Figure 1D)
when exposed to 0.1% O2 for 48 h, whilst the expression
of the control gene alpha-actinin was unaffected by the
hypoxic exposure. A striking reduction of Dicer protein
levels (5.4 fold) was also observed even after a more mod-
est hypoxic exposure (1% O2) for 72 h (Figure 1E).The effect of hypoxia on Dicer protein levels in human
umbilical vein endothelial cells (HUVECs)
To examine whether hypoxic repression of Dicer was also
observed in non cancer cells, human umbilical vein endo-
thelial cells (HUVECs) were studied. HUVECs from mul-
tiple donors were exposed to different durations of hypoxia.
A slight decrease in Dicer protein levels in HUVEC cells
was seen after 1% O2 for 24 h (Figure 1F) and a more strik-
ing decrease (10-fold) after 1% O2 for 48 h (Figure 1G).in expression was examined in SKBR3, MCF7 and HUVEC cells after
tein expression in SKBR3 cells after exposure to 0.1% O2 for 16 h and
for 48 h. D, Dicer protein expression in SKBR3 cells after exposure to
o 1% O2 for 72 h. F, Dicer protein expression in HUVECs after exposure
1% O2 for 48 h (P = 0.1). Dicer and α-actinin protein expression was
reatment.
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cell lines
In previous array data we saw a significant and consistent
repression of Dicer mRNA expression (data not shown).
To examine whether the hypoxic repression of Dicer pro-
tein levels was regulated through repression of Dicer
mRNA levels, we examined Dicer mRNA levels by RT
PCR in MCF7 cells exposed to 0.1% O2 for 8, 16, 24 and
48 h, and observed significant down regulation of Dicer
mRNA expression in hypoxia (Figure 2A). To examine if
this repression was observed in other cancer cell lines
we also examined the response of the colorectal cell
line HT29 to varying durations of hypoxia and saw a
similar, albeit less striking, reduction in Dicer mRNA
levels (Figure 2B). However, no significant changes in
Dicer mRNA levels were observed in SKBR3 breastFigure 2 Dicer mRNA expression in hypoxia vs. normoxia. Dicer mRNA
0.1% O2 for different durations. A, Dicer mRNA expression in MCF7 cells aft
(P = 0.02) and 48 h (P = 0.008). B, Dicer mRNA expression in HT29 cells afte
(P = 0.09). *denotes P < 0.05 compared with parallel controls in normoxia.
levels were analysed by RT-PCR and normalised to 18S rRNA levels. Statisticcancer cells after being exposed to varying durations of
hypoxia (24 h and 48 h, at 0.1% O2) despite seeing sub-
stantial reductions in Dicer protein expression.
The mechanism of hypoxic repression of Dicer
The effect of HIF hydroxylase inhibitors on Dicer levels
HIF plays a central role in the transcriptional response
to hypoxia, so the role of the HIF pathway in the hyp-
oxic repression of Dicer levels was examined. Cells were
exposed to the HIF hydroxylase inhibitors, dimethyloxa-
lyl glycine (DMOG) and desferrioxamine which induce
HIF levels under normoxic conditions [36,39]. A modest
decrease in Dicer mRNA levels was seen after exposing
MCF7 cells to DMOG (1 mM) for 48 h (Figure 3A) and
desferrioxamine (0.1 mM) for 48 h (Figure 3B). A similar
influence on Dicer protein levels was seen followingexpression was examined in MCF7 and HT29 cells after exposure to
er exposure to 0.1% O2 for 8 h (P = 0.0007), 16 h (P = 0.0009), 24 h
r exposure to 0.1% O2 for 16 h (P = 0.01), 24 h (P = 0.02) and 48 h
Data represent normalized mean ± S.E (error bars) (n = 3). Dicer mRNA
al significance established by Student’s t-test.
Figure 3 Dicer mRNA and protein expression after exposure to HIF hydroxylase inhibitors. Dicer mRNA and protein expression was
examined in MCF7 and SKBR3 cells after exposure to HIF hydroxylase inhibitors: dimethyloxalyl glycine (DMOG) and desferrioxamine (DFO)
A, Dicer mRNA expression (P = 0.04) in MCF7 cells after exposure to 1 mM DMOG for 48 h. B, Dicer mRNA expression in SKBR3 cells after
exposure to 0.1 mM DFO for 48 h. *denotes P < 0.05 compared with parallel controls. Data represent normalized mean ± S.E (error bars) (n = 3).
Dicer mRNA levels were analysed by RT-PCR and normalised to 18S rRNA levels. Statistical significance established by Student’s t-test. C, Dicer
protein expression in MCF7 cells after exposure to 1 mM DMOG for 48 h Results show two technical replicates per treatment. D, Dicer protein
expression in SKBR3 cells after exposure to DFO (0.1 mM) for 48 h. Results show three technical replicates per treatment. Dicer and α-actinin
protein expression was examined by immunoblotting. α-actinin was used as the loading control.
Bandara et al. BMC Cancer 2014, 14:533 Page 6 of 18
http://www.biomedcentral.com/1471-2407/14/533exposure to HIF hydroxylase inhibitors. A modest de-
crease in Dicer protein levels was seen in MCF7 cells
after exposure to DMOG (1 mM) for 48 h (Figure 3C).
A more substantial decrease in Dicer protein levels were
seen in SKBR3 cells after exposure to desferrioxamine
(0.1 mM) for 48 h (Figure 3D).
Involvement of HIF in Dicer regulation
To further investigate the involvement of HIF in Dicer
regulation RNA interference was used to inhibit HIF-1α
and HIF-2α, and Dicer levels was examined. The HIF-1α
RNA interference substantially reduced the hypoxic
expression of HIF-1α protein (Figure 4A). The influence
of HIF-1α and HIF-2α isoforms in hypoxic repression of
Dicer was examined. When HIF-1α and HIF-2α wereinhibited simultaneously using RNA interference there
was no effect on the DICER mRNA repression, suggest-
ing a lack of HIF-1α or HIF-2α mediated down regula-
tion of DICER mRNA levels after exposure to hypoxia
(Figure 4B). Substantial repression of Dicer protein was
observed under hypoxia but there was no significant al-
teration in hypoxic repression of Dicer protein after
HIF-1α RNA interference (Figure 4C).
Prolyl hydroxylase dependent regulation of Dicer
These earlier results pointed towards a mechanism of regu-
lation that was oxygen and HIF hydroxylase dependent but
was independent of HIF-1α. To investigate this we used
siRNA mediated suppression of PHD2 expression in
SKBR3 cells and determined the levels of Dicer. A
Figure 4 Dicer repression in hypoxia is not HIF dependent. Dicer expression was examined after HIF-1α and HIF-2α inhibition with siRNA in
hypoxia compared to normoxia A, HIF-1α protein expression in SKBR3 cells after transient transfection with a HIF-1α targeting siRNA or control
siRNA, then exposure to hypoxia (0.1% O2 for 24 h) vs. normoxia. Results show two technical replicates per treatment. B, Dicer mRNA expression
in MCF7 cells after transient transfection with HIF-1α, HIF-2α or control siRNA, then exposure to hypoxia (0.1% O2 for 48 h) vs. normoxia. Data
represent normalized mean ± S.E (error bars) (n = 3). Dicer mRNA levels were analysed by RT q-PCR and normalised to β-2-microglobulin mRNA
levels. C, Dicer protein expression in SKBR3 cells after transient transfection with HIF-1α targeting siRNA or control siRNA, then exposure to
hypoxia (0.1% O2 for 48 h) vs normoxia. Results show two technical replicates per treatment. Dicer and α-actinin protein levels were examined by
immunoblotting. α-actinin was used as the loading control.
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and a large decrease in Dicer protein (Figure 5B) levels,
were evident following PHD2 suppression in normoxia.
This observation was validated by repeating the experiment
with a different PHD2 siRNA and a similar effect was seen
on Dicer expression. PHD2 suppression did not affect
Drosha and TARBP2 protein levels (Figure 5C). We also
examined if the other HIF hydroxylase enzymes (PHDs or
Factor Inhibiting HIF-1 (FIH-1)) were involved in Dicer
regulation by hypoxia. In contrast to the effects of PHD2
suppression, there was no decrease in Dicer expression
after PHD1 (Figure 5D) or FIH-1 RNA interference
(Figure 5E). In keeping with previous work, PHD3 levels
were very low under normoxic conditions [40].The involvement of microRNAs in Dicer regulation
by hypoxia
In other experimental settings, the feedback regulation of
Dicer by specific Dicer dependent miRNAs has been re-
ported to be important in controlling Dicer levels [41,42].
We therefore hypothesised that a hypoxically induced
miRNA might mediate the hypoxic repression of Dicer ex-
pression. miR-210 is the best characterised example of a
miRNA that shows substantial induction under hypoxic
conditions. We examined the influence of miR-210 manip-
ulations on Dicer expression. miR-210 was over-expressed
in normoxia by transient transfection of SKBR3 cells with a
miR-210 mimic and a control mimic (Figure 6A). We de-
termined Dicer mRNA (Figure 6B) and protein (Figure 6C)
Figure 5 Prolyl hydroxylase dependent regulation of Dicer. Dicer expression was examined in SKBR3 cells after inhibition of each prolyl
hydroxylase by siRNAs. A, Dicer mRNA expression in SKBR3 cells after transient transfection with PHD2 targeting siRNAs or control siRNA in
normoxia (P = 0.0008). *denotes P < 0.05 compared with parallel controls. Data represent normalized mean ± S.E (error bars) (n = 3). Dicer mRNA
levels were analysed by RT-PCR and normalised to β-2-microglobulin mRNA levels. Statistical significance established by Student’s t-test.
B, PHD2 and Dicer protein levels after transient transfection of SKBR3 cells with two independent siRNAs targeting PHD2 or control siRNAs in
normoxia. Results show two technical replicates per treatment. C, Dicer, Drosha and TARBP2 protein expression after transient transfection of
SKBR3 cells with siRNAs targeting PHD2 or control siRNAs in normoxia. D, Dicer protein expression after transient transfection of SKBR3 cells with
siRNAs targeting PHD1 siRNAs or control siRNAs in normoxia. E, Dicer protein expression after transient transfection of SKBR3 cells with siRNAs
targeting FIH-1 siRNA or control siRNA in normoxia. Results show three technical replicates per treatment. Protein expression was examined by
immunoblotting. α-actinin was used as the loading control.
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crease in Dicer mRNA levels was observed with miR-
210 over-expression, and Dicer levels were not affected
by the miR-210 antagomir in normoxic or hypoxic con-
ditions (Figure 6D).
To further test possible miRNA involvement in Dicer
regulation, we examined for the hypoxic regulation of
miRNAs with well characterised roles in Dicer regulation.
Martello et al., (2010) found conserved binding sites for
miR-103/107 family in the 3’UTR of DICER. With the aid
of luciferase reporter constructs containing the wild type
or mutant miR-103/107 binding sites they showed that
Dicer is regulated by these two miRNAs. In addition, miR-
103 and miR-107 have also been identified to decreasemiRNA biogenesis by targeting Dicer in cancer [41] and
have been reported to show hypoxic induction in some sit-
uations [32]. We examined miR-103 and miR-107 levels in
MCF7 cells after exposure to hypoxia (0.1% O2 for 16, 24
and 48 h) vs. normoxia to see if these miRNAs were
affected by hypoxia. There was a modest increase in miR-
103 levels after 24 h of hypoxia (0.1% O2) and a more sig-
nificant increase after 48 h of hypoxia (Figure 7A). There
was an increase in miR-107 levels after 16 h of hypoxia
(0.1% O2) and at 24 and 48 h (Figure 7B). To examine if
the down regulation of Dicer levels in hypoxia was regu-
lated by these two miRNAs, the effects of miR-103/107
antagomirs was tested on Dicer protein expression under
hypoxia and normoxia by immunoblotting. In keeping
Figure 6 Dicer expression in not regulated by miR-210 in
hypoxia. Dicer expression was examined after transient transfection
with a miR-210 mimic and miR-210 antagomir in SKBR3 cells. A,
miR-210 expression in SKBR3 cells after transient transfection with
control mimic and miR-210 mimic and miR-210 antagomir in normoxia.
B, Dicer mRNA expression in SKBR3 cells after transient transfection
with control mimic and miR-210 mimic. C, Dicer protein expression in
SKBR3 cells after transfection with control mimic and miR-210 mimic.
Results show three technical replicates per treatment. D, Dicer mRNA
expression in SKBR3 cells after transient transfection with control mimic,
miR-210 mimic and miR-210 inhibitor, then exposed to 1% O2 for 72 h.
Data represent normalized mean ± S.E (error bars) (n = 3). mRNA levels
were analysed by RT-PCR and normalised to β-2-microglobulin mRNA
levels. Statistical significance established by Student’s t-test. Dicer and
β-tubulin protein levels were examined by immunoblotting. β-tubulin
was used as the loading control.
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of Dicer expression, the blocking of miR-103/107 func-
tion abrogated the hypoxic repression of Dicer levels
(Figure 7C).
Hypoxic regulation of other miRNA biogenesis proteins
The hypoxic regulation of other proteins involved in the
miRNA biogenesis process was also examined. A con-
sistent repression of Drosha (Figure 8A) and TARBP2
(Figure 8B) mRNA expression, measured by RT-PCR, was
observed in MCF7 cells exposed to 0.1% O2 for 48 h. Pro-
tein levels were also examined after exposure to 0.1% O2
for 48 h, and there was a striking down regulation of
Drosha, TARBP2, DGCR8 and XPO5 protein levels in
hypoxia (Figure 8C). The control protein levels (α-actinin
and β-tubulin) did not change following these severities
and durations of hypoxic exposures.
Co-ordinated expression of miRNA biogenesis proteins
Given the hypoxic down regulation of many proteins in-
volved in miRNA biogenesis, the mechanisms responsible
for this effect was examined. Previously others had shown a
strong correlation between Dicer protein and TARBP2 pro-
tein levels [11,43]. To investigate possible co-ordinated con-
trol of protein levels, specific RNA interference was used to
inhibit the expression of each gene and then the levels of
the other proteins were analysed by immunoblotting.
When Dicer was inhibited using RNA interference a
large decrease in TARBP2 levels (Figure 9A) was observed,
in keeping with previous reports [43]. Similarly, when
TARBP2 levels were reduced by RNA interference in
SKBR3 cells there was a modest decrease in Dicer protein
expression (Figure 9B). When Dicer and TARBP2 levels
were studied over a time course both proteins seemed to
decrease at the same rate (Figure 9C). A relationship be-
tween Dicer and Drosha levels was also observed with an
increase in Drosha protein expression after inhibiting
Dicer (Figure 9D) while a decrease in Dicer protein levels
was seen after Drosha inhibition by siRNA treatment
(Figure 9E).
Mature and precursor microRNA levels in hypoxia
The previous results indicated that hypoxia down regu-
lates proteins involved in the miRNA biogenesis pathway.
For a more comprehensive understanding of the global ef-
fects of hypoxia vs. normoxia on miRNA biogenesis, ma-
ture and precursor miRNA levels were compared using
Affymetrix miRNA 3.1 arrays. Mature and precursor
miRNA levels in MCF7 cells exposed to hypoxia (0.1% O2
for 16 h) or normoxia were analysed. In keeping with the
modest changes in Dicer expression at this time point, no
significant changes were observed in mature or precursor
miRNA levels in MCF7 cells exposed to hypoxia (0.1% O2)
vs. normoxia after 16 h (data not shown).
Figure 7 Dicer repression by miR-103 and miR-107 in hypoxia. Expression of miR-103 and miR-107 were examined in MCF7 cells, after
exposure to 0.1% O2 for different durations. A, miR-103 expression in MCF7 cells after hypoxia (0.1% O2 for 16, 24 and 48 h) vs. normoxia (P = 0.03).
B, miR-107 expression in MCF7 cells after hypoxia (0.1% O2 for 16, 24 and 48 h) vs. normoxia (P = 0.04). * denotes p < 0.05 compared with parallel
controls. Data represent normalized mean ± S.E (error bars) (n = 3). miRNA levels were analysed by q-RT PCR and normalised to U6 levels. Statistical
significance established by Student’s t-test. Dicer expression was examined after transient transfection with miR-103/107 inhibitors and exposure to
hypoxia vs. normoxia. C, Dicer protein expression after transfection of MCF7 cells with miR-103/107 inhibitors or control inhibitors and exposure to
hypoxia (0.1% O2 for 48 h) vs. normoxia. Results show three technical replicates per treatment. Dicer and α-actinin protein levels were examined by
immunoblotting. α-actinin was used as the loading control.
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ation of hypoxic exposure (0.1% O2 for 48 h) several miR-
NAs were significantly up or down regulated in MCF7 cells
(see Additional file 1: Figure S1). Eight miRNAs were sig-
nificantly up regulated (see Additional file 1: Table S2), and
four miRNAs were significantly down regulated in hypoxia
when compared to normoxia (see Additional file 1: Table
S3). Even following a longer duration of hypoxic exposure
(0.1% O2 for 48 h) there were no significant changes be-
tween individual precursor miRNA: mature miRNA ratios
either with hypoxia (see Additional file 1: Figure S2) or,
surprisingly, following Dicer suppression by siRNA (see
Additional file 1: Figure S3-S4). The microarray data dis-
cussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus [38] and are accessible through
GEO Series accession number GSE49999.To explore the effects of hypoxia on the processing of
specific miRNAs with a different assay, the levels of ma-
ture and precursor miRNA levels of let-7a, miR-21 and
miR-185 were determined in MCF7 cells exposed to hyp-
oxia vs. normoxia, by RT-PCR. These were selected as pre-
vious reports showed they were Dicer dependent miRNAs
[44-46]. Only a modest decrease in mature and precursor
levels of let-7a and miR-21 in hypoxia was observed, and
no accumulation of pre-let-7a or pre-miR-21 in hypoxia
was evident (Figure 10A, 10B). A significant reduction
(P = 0.03) in mature miR-185 was observed in hypoxia in
MCF7 cells (Figure 10C), but no accumulation of precur-
sors was seen. Furthermore following the recent report of
hypoxia reducing miRNA processing by Ho et al. [45] in
HUVEC cells, the ratio of mature and pre-miRNA levels
for miR-185 and miR-21 was examined in these cells.
Figure 8 Hypoxic regulation of other miRNA biogenesis proteins. Expression of miRNA biogenesis proteins Drosha, TARBP2, DGCR8 and
XPO5 were examined under hypoxia vs. normoxia A, Drosha mRNA expression in SKBR3 cells after hypoxia (0.1% O2 48 h) vs. normoxia (P = 0.05).
B, TARBP2 mRNA expression in SKBR3 cells after hypoxia (0.1% O2 48 h) vs. normoxia (P = 0.03). *denotes P < 0.05 compared with parallel
controls. Data represent normalized mean ± S.E (error bars) (n = 3). mRNA levels were analysed by RT-PCR and normalised to 18S rRNA levels.
C, Drosha, TARBP2, DGCR8 and XPO5 protein expression in SKBR3 cells after hypoxia (0.1% O2 48 h) vs. normoxia. Results show three technical
replicates per treatment. Protein levels were examined by immunoblotting. α-actinin and β-tubulin used as the loading controls.
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http://www.biomedcentral.com/1471-2407/14/533However, following both 24 and 48 h of 1% hypoxia again
there was no clear effect on processing (see Additional
file 1: Figure S4-S5). Therefore, only a minimal overall
effect on miRNA processing was observed for these
specific miRNAs, consistent with the lack of effect on
processing as seen in the microarray experiment.
The effect of hypoxia on microRNA function
Given the multiple potential influences of hypoxia on
miRNA biogenesis proteins and RISC activity, the effectsof hypoxia on miRNA function were studied. For this a
plasmid containing the 3’UTR of ZEB1 gene down-
stream of a Renilla luciferase (RL) reporter was used [37]
along with a plasmid that expresses a pre-miR-200b. ZEB1
is an E-cadherin transcriptional repressor involved in epi-
thelial to mesenchymal transition of tissues and is regulated
by the miR-200 family. SKBR3 cells were co-transfected
with a plasmid containing the 3’UTR from the ZEB1 gene
downstream of a Renilla luciferase reporter (pCi-neo-
ZEB1-hRL) together with precursor miR-200b (pCMV-
Figure 9 Co-ordinated expression of miRNA biogenesis proteins. A, Dicer and TARBP2 protein expression in SKBR3 cells after transient
transfection with siRNA targeting Dicer or control siRNA. Results show three technical replicates per treatment. B, TARBP2 and Dicer protein
expression in SKBR3 cells after transient transfection with siRNA targeting TARBP2 or control siRNA. C, Changes in Dicer and TARBP2 protein
expression after exposure to 16, 24 and 48 h of hypoxia. D, Dicer and Drosha protein expression in SKBR3 cells after transient transfection with
siRNA targeting Dicer or control siRNA. Results show three technical replicates per treatment. E, Dicer and Drosha protein expression in SKBR3
cells after transient transfection with siRNA targeting Drosha or control siRNA. Results show three technical replicates per treatment. F and G,
total protein on PVDF membranes. H and I, Densitometric analysis of D and E following normalisation with total protein on PVDF membrane.
Protein levels were examined by immunoblotting. α-actinin, β-tubulin or total protein on the PVDF membrane were used as the loading controls.
Bandara et al. BMC Cancer 2014, 14:533 Page 12 of 18
http://www.biomedcentral.com/1471-2407/14/533miR-200b) or empty vector (pCMV-miR), then cells were
exposed to hypoxia (0.1% O2 for 24 h) or normoxia, and lu-
ciferase activity was measured. ZEB1 3’UTR contains miR-
200b target sites and binding of the mature miR-200b will
repress the RL activity. The luminescence measured with
pCi-neo-ZEB1-hRL + pCMV-miR-200b showed a sig-
nificant repression in normoxia when compared to hyp-
oxia, suggesting less miR-200b mediated suppression in
hypoxia (Figure 11). No change in luminescence was
seen in the control (pCi-neo-ZEB1-hRL + pCMV-miR)
transfection after incubation in hypoxia compared with
normoxia (Figure 11). Results show data from two inde-
pendent experiments each with three technical replicates.
Discussion
This study examined the hypoxic regulation of miRNA
biogenesis proteins in cancer cells. Results showed thathypoxia down regulates the levels of Dicer and several
other proteins (Drosha, TARBP2, DGCR8 and XPO5) in]
volved in miRNA biogenesis. The hypoxic down regulation
of Dicer protein levels was observed in multiple cell lines,
suggesting that this could be a common phenomenon and
not restricted to cancer cells. The reductions in Dicer pro-
tein levels were much more significant following longer du-
rations of hypoxia (for 48 and 72 h) and with greater
severity of hypoxic exposure (0.1% O2). One likely explan-
ation for this observation is high stability of Dicer protein.
Therefore, the decrease in transcription might not be read-
ily evident until 48 h. Consistent with this explanation, only
modest reductions in Dicer protein levels were observed at
shorter durations of hypoxic exposure. The mechanism of
this hypoxic regulation appears to operate at several levels.
The hypoxic suppression of Dicer mRNA levels appears to
account for regulation in some (MCF7 and HT29) but not
Figure 10 Mature and precursor expression in hypoxia vs. normoxia. A, Pre-let-7a and mature let-7a expression, precursor/mature ratio in
MCF7 cells exposed to hypoxia (0.1% O2 for 48 h) vs. normoxia. B, Pre-miR-21 and miR-21 expression, precursor/mature ratio in MCF7 cells
exposed to hypoxia (0.1% O2 for 48 h) vs. normoxia. C, Pre-miR-185 and miR-185 expression, precursor/mature ratio in MCF7 cells exposed to
hypoxia (0.1% O2 for 48 h) vs. normoxia. Data represent normalized mean ± S.E (error bars) (n = 3). miRNA levels were analysed by RT-PCR and
normalised to RNU6B levels.
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Figure 11 miRNA processing is affected by hypoxia. Luciferase activity in SKBR3 cells after co-transfection with RL reporter containing a ZEB1
WT with miR-200b target sites (pCi-neo-ZEB1-hRL) and precursor miR-200b (pCMV-miR-200b) or empty vector (pCMV-miR) (Origene), then exposure to
hypoxia (0.1% O2 24 h) vs. normoxia (P = 0.04). *denotes P < 0.05 compared with parallel controls. Data represent normalized mean ± S.E (error bars)
from two independent experiments consisting of three technical replicates.
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http://www.biomedcentral.com/1471-2407/14/533all cells (e.g. SKBR3) indicating the operation of other
mechanisms in the hypoxic regulation of Dicer. During the
course of this work, hypoxic repression of Dicer mRNA
and protein was also reported by others [34,45,47]. In ex-
ploring the mechanism of hypoxic regulation, we investi-
gated the role of HIF and the HIF hydroxylases. In
keeping with a role for the HIF hydroxylases in mediating
this hypoxic repression, when cells were exposed to the
HIF hydroxylase inhibitors, DMOG and desferrioxamine,
a modest decrease in Dicer mRNA and protein levels was
observed in MCF7 cells. However, somewhat surprisingly
no, or very modest, effects on the repression of Dicer
mRNA and protein levels were observed after HIF-1α and
HIF-2α inhibition using siRNA treatments. This suggested
that HIF did not play a major role in this hypoxic regula-
tion of Dicer, a conclusion also reached by Ho et al. (2012)
[45], However, in a recent study Camps, et al. (2014) re-
ported down regulation of Dicer mRNA levels in hypoxia
in a HIF dependent manner [48].
Our results indicate a mechanism of regulation that is
oxygen and HIF hydroxylase dependent but independentof HIF. To explore this mechanism further, we examined
for the possible contribution of each of the three HIF pro-
lyl hydroxylases (PHD1, 2 and 3) and the HIF asparaginyl
hydroxylase, FIH-1. When PHD2 was suppressed by RNA
interference in normoxic conditions significant decreases
in Dicer mRNA and protein expression were observed in
normoxia, indicating a role for PHD2 in this hypoxic regu-
lation. Interestingly, a recent study described a PHD2
dependent, but HIF independent, pathway for repressing
protein synthesis in hypoxia. They reported of a PHD2
mediated phosphorylation of the eukaryotic elongation
factor-2 and inhibition of protein translation under acute
hypoxia [49]. In keeping with such a mechanism, the other
HIF hydroxylase enzymes (PHD1, PHD3) and FIH-1 were
not involved in Dicer regulation by hypoxia.
In further exploring the mechanisms of hypoxic regula-
tion and given the importance of miRNA mediated feed-
back loops in control of Dicer expression [41,42], we
examined possible influence of hypoxically induced miR-
NAs in mediating hypoxic repression of Dicer expression.
Hypoxically induced miR-210 is the best characterised
Bandara et al. BMC Cancer 2014, 14:533 Page 15 of 18
http://www.biomedcentral.com/1471-2407/14/533example of a miRNA that shows substantial induction
under hypoxic conditions [32,50] but had no significant
influence on the levels of Dicer protein.
Two miRNAs, miR-103 and miR-107 have been shown
to decrease miRNA biogenesis by targeting Dicer in can-
cer [41] and are reportedly induced by hypoxia in some
situations [32]. To examine their potential contribution
to hypoxic repression of Dicer, cells were exposed to
hypoxia after inhibiting miR-103 and miR-107 with
antagomirs. The repression of Dicer mRNA and protein
levels in hypoxia was largely abrogated, consistent with a
role for miR-103 and miR-107 in the hypoxic regulation
of Dicer.
Other proteins involved in miRNA biogenesis (Drosha,
TARBP2, DGCR8 and XPO5) also showed significant
down regulation under hypoxia when compared to nor-
moxia. A previous microarray study also showed modest
but consistent hypoxic reductions in mRNA levels of
genes (Dicer, TARBP2 and AGO2) involved in miRNA
biogenesis [36]. Ho et al. (2012) also reported a decrease
in DGCR8 and XPO5 protein levels in hypoxia, (though
they did not see a decrease in Drosha levels in hypoxia)
[45]. This suggests the operation of a broader influence
of hypoxia on the expression of genes encoding proteins
that are essential in miRNA biogenesis. This is consist-
ent with previous work indicating co-ordinate regulation
of the levels of these proteins. When Dicer expression
was suppressed there was a significant decrease in
TARBP2 levels in keeping with previous reports [43].
Similarly, when TARBP2 levels were reduced by siRNA
treatment there was a modest decrease in Dicer protein.
When Dicer and TARBP2 levels were examined over a
time course of hypoxic exposure both proteins seemed
to decrease co-ordinately. Previously others have shown
a powerful influence of the levels of Dicer protein on the
levels of TARBP2 and vice versa [11,43] and post tran-
scriptional cross regulation between Drosha and DGCR8
[51]. In this work we have also observed a further rela-
tionship linking Dicer and Drosha expression. Recent
work has shown that Argonaute 2 stability is dependent
on the availability of mature miRNAs. Dicer knockout
influenced the mature miRNA production leading to de-
creased AGO2 stability [52]. Similar mechanisms might
be operating to co-ordinate the levels of other miRNA
biogenesis proteins in hypoxia.
Even though there was a significant and consistent re-
duction in the levels of proteins with central roles in
miRNA biogenesis machinery under hypoxia, we did not
see a substantial effect of this on the expression levels of
mature miRNAs over the time course of these experi-
ments. Indeed under these conditions Dicer suppression
by RNA interference was only associated with slight al-
terations in mature miRNA abundance. This was true
both for miRNAs assessed by microarray studies andalso when we focussed on examining the levels of par-
ticular miRNAs and their precursors by RT-PCR. Micro-
array analysis of MCF7 cells exposed to hypoxia showed
eight miRNAs were significantly up regulated and four
miRNAs were significantly down regulated. Of the eight
up regulated miRNAs, miR-210 has been well validated
as a highly induced miRNA in hypoxia [35]. The lack of
impairment of miR-210 maturation even after the de-
crease of many miRNA biogenesis proteins in hypoxia
could be due to robustly increased transcription of the
miR-210 gene in hypoxia. Recently deep sequencing of
miRNA populations in hypoxic and normoxic HUVECs
also showed no significant difference in the majority of
miRNA species [53]. Camps et al. (2014) reported down
regulation of Dicer mRNA in hypoxia but failed to see a
global down regulation of miRNAs in hypoxia compared
to normoxia using small RNA sequencing techniques
[48]. They reported that 41 miRNAs were up regulated
and 28 miRNAs were down regulated in hypoxia com-
pared to normoxia in MCF7 cells [48]. This work pro-
vides further support for Dicer down regulation by
hypoxia but minimal influences on miRNA maturation.
In MCF7 cells only a modest decrease in mature and
precursor levels of let-7a and miR-21 was seen after ex-
posure to hypoxia, and we did not see an accumulation
of pre-let-7a or pre-miR-21 in hypoxia. A significant re-
duction (P = 0.03) in mature miR-185 was observed in
hypoxia in MCF7 cells, but there was no accumulation
of precursors. These miRNAs (let-7a, miR-21 and miR-
185) were chosen as previous reports showed they were
Dicer dependent miRNAs and mature levels decreased
with Dicer inhibition [44-46].
The use of knockout murine models has provided
compelling evidence for the essential role of Dicer in
mature miRNA production. However, it has proven
more difficult to clearly see such critical influences in
a variety of experiments that have utilised siRNA
mediated Dicer suppression [44,54]. Others have pre-
viously explored the surprising stability of some miR-
NAs with an average miRNA half-life of 119 h [55],
and this may largely explain the lack of changes in
mature miRNA levels after 48 h of hypoxia or Dicer
suppression by siRNA. The operation of Dicer inde-
pendent pathways in the generation of miRNAs has
been well described for a small number of specific
miRNAs [56-58] but seems a less plausible explan-
ation for the lack of influence of Dicer manipulations
on global alterations in miRNA abundance. Another
possibility is that the levels of proteins such as Dicer
are not rate limiting for the production of miRNAs
under these conditions. These observations suggest
that early and immediate responses to hypoxic stresses
are not likely to be mediated by global alterations in
mature miRNA levels.
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http://www.biomedcentral.com/1471-2407/14/533During the course of this work, Ho et al. (2012) also
described a reduction in Dicer levels after exposure to
hypoxia, and reported a decrease in the levels of sev-
eral mature miRNAs and an accumulation of their
precursor-miRNAs in HUVEC cells [45]. Whilst we
were unable to replicate these findings using precisely
controlled levels of hypoxia, this may suggest that in
particular cells or conditions of hypoxic exposure, the
hypoxic repression of Dicer can have important influ-
ences on miRNA biogenesis.
Whilst hypoxia exerted only modest effects on the
production of mature miRNAs, we did see a significant
influence of hypoxia on the operation of an exogenously
introduced precursor miRNA. The processing and func-
tion of miR-200b was reduced in hypoxia when com-
pared to normoxia. Dicer and TARBP2 proteins are
involved in the processing of a precursor miRNA in to a
mature miRNA and the reduction of both these proteins
in hypoxia would likely have impacted on the maturation
of the pre-miR-200b.
This work points towards the operation of non-HIF
but HIF hydroxylase dependent pathways by which hyp-
oxia controls reductions in gene expression. This effect
of hypoxia appears to operate via several mechanisms of
regulation and we have shown important influences of
the HIF hydroxylase PHD2 and of the hypoxically regu-
lated miRNAs miR-103 and miR-107 in this regulation.
Furthermore, there appears to be co-ordinated regula-
tion of several of the proteins involved in miRNA bio-
genesis under hypoxic and other conditions. However,
influences on mature miRNA production were more
modest than might have been anticipated from the sub-
stantial hypoxic reductions in protein expression of
Dicer, Drosha, TARBP2 and XPO5. The breadth of this
effect suggests a further and important interface be-
tween oxygen availability and gene expression.Conclusion
These observations show an important interface between
oxygen availability and gene expression via alterations in
the levels of proteins critical for miRNA generation. This
may provide a mechanistic explanation for the reduced
levels of miRNAs observed in some cancers and provides
evidence for the existence of a co-ordinated mechanism of
repression of levels of miRNA biogenesis proteins in re-
sponse to hypoxia. There is a PHD2 dependent, but HIF
independent, mechanism of repression of these proteins
under hypoxic conditions. These results also provide fur-
ther support for the existence of feedback mechanisms in
the regulation of the miRNA biogenesis pathway. Despite
such mechanisms, short term modulation of miRNA bio-
genesis in breast cancer cells only leads to modest effects
on miRNA levels in keeping with their significant stability.Additional file
Additional file 1: Table S1. List of siRNA sequences. Table S2. miRNAs
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miRNA in MCF7 cells after Dicer inhibition by transient transfection with
siRNAs vs. normoxia. Figure S4. Dicer protein expression in MCF7 cells after
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